Development and Characterization of Solid Dispersion System for Enhancing the Solubility and Dissolution Rate of Dietary Capsaicin

Author(s): Sumit Bera, Subhasis Maity, Balaram Ghosh, Animesh Ghosh, Tapan K. Giri*

Journal Name: Current Drug Therapy

Volume 15 , Issue 2 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Capsaicin is a pungent component of chili peppers that suppresses the growth of various cancer cell lines including breast cancer. However, it shows extremely low oral bioavailability due to its poor water solubility.

Objective: The objective of the present work was to improve the solubility and dissolution rate of capsaicin.

Methods: Solid dispersions were prepared by the solvent evaporation method using different molar ratios of capsaicin and urea (1:1, 1:2, and 1:3). Differential Scanning Calorimetry (DSC) and X-Ray Diffraction (XRD) study were used to characterize the solid dispersion. Solid dispersions were evaluated for solubility, dissolution rate and in vitro cytotoxicity in breast cancer cell lines.

Results: XRD and DSC studies exhibited the reduced crystallinity of a drug in solid dispersion. Phase solubility study shows that the drug solubility increased by increasing carrier concentration. In vitro release study of the solid dispersion showed the faster dissolution of a drug with increasing carrier concentration. Solid dispersion formulation effectively inhibited the growth of MCF-7 human breast cancer and MDA-MB-231 triple negative human breast cancer cells in an MTT assay that measures metabolic activity, but only slightly decreased cell viability when compared to capsaicin alone.

Conclusion: The present study demonstrated that solid dispersion of capsaicin in PEG 6000 overcomes the problems related to the poor aqueous solubility of this drug and improving its dissolution rate.

Keywords: Capsaicin, breast cancer, cytotoxicity, solid dispersion, bioavailability, in vitro.

[1]
Giri TK, Pramanik K, Barman TK, Maity S. Nano-encapsulation of dietary phytoconstituent capsaicin on emulsome: evaluation of anticancer activity through the measurement of liver oxidative stress in rats. Anticancer Agents Med Chem 2017; 17(12): 1669-78.
[PMID: 28425858]
[2]
Giri TK, Bhowmick S, Maity S. Entrapment of capsaicin loaded nanoliposome in pH responsive hydrogel beads for colonic delivery. J Drug Deliv Sci Technol 2017; 39: 417-22.
[http://dx.doi.org/10.1016/j.jddst.2017.05.002]
[3]
Chhabra N, Aseri ML, Goyal V, Sankhla S. Capsaicin: A promising therapy-A critical reappraisal. Int J Nutr Pharmacol Neurol Dis 2012; 2: 8-15.
[http://dx.doi.org/10.4103/2231-0738.93124]
[4]
Giri TK, Mukherjee P, Barman TK, Maity S. Nano-encapsulation of capsaicin on lipid vesicle and evaluation of their hepatocellular protective effect. Int J Biol Macromol 2016; 88: 236-43.
[http://dx.doi.org/10.1016/j.ijbiomac.2016.03.056] [PMID: 27032489]
[5]
Díaz-Laviada I. Effect of capsaicin on prostate cancer cells. Future Oncol 2010; 6(10): 1545-50.
[http://dx.doi.org/10.2217/fon.10.117] [PMID: 21062154]
[6]
Sarkar A, Bhattacharjee S, Mandal DP. Induction of Apoptosis by Eugenol and Capsaicin in Human Gastric Cancer AGS Cells--Elucidating the Role of p53. Asian Pac J Cancer Prev 2015; 16(15): 6753-9.
[http://dx.doi.org/10.7314/APJCP.2015.16.15.6753] [PMID: 26434906]
[7]
Shin DH, Kim OH, Jun HS, Kang MK. Inhibitory effect of capsaicin on B16-F10 melanoma cell migration via the phosphatidylinositol 3-kinase/Akt/Rac1 signal pathway. Exp Mol Med 2008; 40(5): 486-94.
[http://dx.doi.org/10.3858/emm.2008.40.5.486] [PMID: 18985006]
[8]
Sietsema WK, Berman EF, Farmer RW, Maddin CS. The antinociceptive effect and pharmacokinetics of olvanil following oral and subcutaneous dosing in the mouse. Life Sci 1988; 43(17): 1385-91.
[http://dx.doi.org/10.1016/0024-3205(88)90305-0] [PMID: 3185099]
[9]
Donnerer J, Amann R, Schuligoi R, Lembeck F. Absorption and metabolism of capsaicinoids following intragastric administration in rats. Naunyn Schmiedebergs Arch Pharmacol 1990; 342(3): 357-61.
[http://dx.doi.org/10.1007/BF00169449] [PMID: 2280802]
[10]
Ludy MJ, Moore GE, Mattes RD. The effects of capsaicin and capsiate on energy balance: critical review and meta-analyses of studies in humans. Chem Senses 2012; 37(2): 103-21.
[http://dx.doi.org/10.1093/chemse/bjr100] [PMID: 22038945]
[11]
Zi P, Yang X, Kuang H, Yang Y, Yu L. Effect of HPbetaCD on solubility and transdermal delivery of capsaicin through rat skin. Int J Pharm 2008; 358(1-2): 151-8.
[http://dx.doi.org/10.1016/j.ijpharm.2008.03.001] [PMID: 18417302]
[12]
Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971; 60(9): 1281-302.
[http://dx.doi.org/10.1002/jps.2600600902] [PMID: 4935981]
[13]
Nkansah P, Antipas A, Lu Y, et al. Development and evaluation of novel solid nanodispersion system for oral delivery of poorly water-soluble drugs. J Control Release 2013; 169(1-2): 150-61.
[http://dx.doi.org/10.1016/j.jconrel.2013.03.032] [PMID: 23570985]
[14]
Zerrouk N, Chemtob C, Arnaud P, Toscani S, Dugue J. In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions. Int J Pharm 2001; 225(1-2): 49-62.
[http://dx.doi.org/10.1016/S0378-5173(01)00741-4] [PMID: 11489554]
[15]
Sotthivirat S, McKelvey C, Moser J, Rege B, Xu W, Zhang D. Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364. Int J Pharm 2013; 452(1-2): 73-81.
[http://dx.doi.org/10.1016/j.ijpharm.2013.04.037] [PMID: 23651642]
[16]
Mohammadi G, Hemati V, Nikbakht MR, et al. In vitro and in vivo evaluation of clarithromycin–urea solid dispersions prepared by solvent evaporation, electrospraying and freeze drying methods. Powder Technol 2014; 257: 168-74.
[http://dx.doi.org/10.1016/j.powtec.2014.03.014]
[17]
Craig DQM. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 2002; 231(2): 131-44.
[http://dx.doi.org/10.1016/S0378-5173(01)00891-2] [PMID: 11755266]
[18]
Kang JH, Yan YD, Kim HC, Lee SN, Yong CS, Choi HG. Enhanced dissolution of coenzyme Q10 using solid dispersions prepared by low temperature melting method. J Pharm Investig 2010; 40: 277-83.
[http://dx.doi.org/10.4333/KPS.2010.40.5.277]
[19]
Dajani EZ, Larsen KR, Taylor J, et al. 1′,1′-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties. J Pharmacol Exp Ther 1999; 291(1): 31-8.
[PMID: 10490883]
[20]
Nozaki Y, Tanford C. The solubility of amino acids and two glycine peptides in aqueous ethanol and dioxane solutions. Establishment of a hydrophobicity scale. J Biol Chem 1971; 246(7): 2211-7.
[PMID: 5555568]
[21]
Giri TK, Pradhan M, Tripathi DK. Synthesis of graft copolymer of kappa-carrageenan using microwave energy and studies of swelling capacity, flocculation properties, and preliminary acute toxicity. Turk J Chem 2016; 40: 283-95.
[http://dx.doi.org/10.3906/kim-1503-16]
[22]
Giri TK, Verma D, Tripathi DK. Effect of adsorption parameters on biosorption of Pb++ ions from aqueous solution by poly (acrylamide)-grafted kappa-carrageenan. Polym Bull 2015; 72: 1625-46.
[http://dx.doi.org/10.1007/s00289-015-1357-9]
[23]
Giri TK, Dey B, Maity S. Preparation and characterization of nanoemulsome entrapped in enteric coated hydrogel beads for the controlled delivery of capsaicin to the colon. Curr Drug Ther 2018; 13: 98-105.
[http://dx.doi.org/10.2174/1574885512666171107151526]
[24]
Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001; 13(2): 123-33.
[http://dx.doi.org/10.1016/S0928-0987(01)00095-1] [PMID: 11297896]
[25]
Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 2005; 11: 127-52.
[http://dx.doi.org/10.1016/S1387-2656(05)11004-7] [PMID: 16216776]
[26]
Kumari P, Swami MO, Nadipalli SK, Myneni S, Ghosh B, Biswas S. Curcumin delivery by poly (Lactide)-based co-polymeric micelles: an in vitro anticancer study. Pharm Res 2016; 33(4): 826-41.
[http://dx.doi.org/10.1007/s11095-015-1830-z] [PMID: 26597940]
[27]
Hayman M, Kam PCA. Capsaicin: A review of its pharmacology and clinical applications. Curr Anaesth Crit Care 2008; 19: 338-43.
[http://dx.doi.org/10.1016/j.cacc.2008.07.003]
[28]
Adibkia K, Javadzadeh Y, Dastmalchi S, Mohammadi G, Niri FK, Alaei-Beirami M. Naproxen-eudragit RS100 nanoparticles: preparation and physicochemical characterization. Colloids Surf B Biointerfaces 2011; 83(1): 155-9.
[http://dx.doi.org/10.1016/j.colsurfb.2010.11.014] [PMID: 21130612]
[29]
Mohammadi G, Valizadeh H, Barzegar-Jalali M, et al. Development of azithromycin-PLGA nanoparticles: physicochemical characterization and antibacterial effect against Salmonella typhi. Colloids Surf B Biointerfaces 2010; 80(1): 34-9.
[http://dx.doi.org/10.1016/j.colsurfb.2010.05.027] [PMID: 20558048]
[30]
Almeida MA, Nadal JM, Grassiolli S, et al. Enhanced gastric tolerability and improved anti-obesity effect of capsaicinoids-loaded PCL microparticles. Mater Sci Eng C 2014; 40: 345-56.
[http://dx.doi.org/10.1016/j.msec.2014.03.049] [PMID: 24857502]
[31]
Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm 2004; 272(1-2): 1-10.
[http://dx.doi.org/10.1016/j.ijpharm.2003.11.025] [PMID: 15019063]
[32]
Frank HS, Franks F. Structural approach to the solvent power of water for hydrocarbons; urea as a structure breaker. J Chem Phys 1968; 48: 4746-57.
[http://dx.doi.org/10.1063/1.1668057]
[33]
Ruan LP, Yu BY, Fu GM, Zhu DN. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J Pharm Biomed Anal 2005; 38(3): 457-64.
[http://dx.doi.org/10.1016/j.jpba.2005.01.030] [PMID: 15925247]
[34]
Kim EJ, Chun MK, Jang JS, Lee IH, Lee KR, Choi HK. Preparation of a solid dispersion of felodipine using a solvent wetting method. Eur J Pharm Biopharm 2006; 64(2): 200-5.
[http://dx.doi.org/10.1016/j.ejpb.2006.04.001] [PMID: 16750355]
[35]
Van den Mooter G, Augustijns P, Blaton N, Kinget R. Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm 1998; 164: 67-80.
[http://dx.doi.org/10.1016/S0378-5173(97)00401-8]
[36]
Chang HC, Chen ST, Chien SY, Kuo SJ, Tsai HT, Chen DR. Capsaicin may induce breast cancer cell death through apoptosis-inducing factor involving mitochondrial dysfunction. Hum Exp Toxicol 2011; 30(10): 1657-65.
[http://dx.doi.org/10.1177/0960327110396530] [PMID: 21300690]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 2
Year: 2020
Page: [143 - 151]
Pages: 9
DOI: 10.2174/1574885514666190724143351
Price: $65

Article Metrics

PDF: 11
HTML: 2
EPUB: 1
PRC: 1